|
1
|
Jemal A, Bray F, Center MM, Ferley J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society. Cervical cancer:
What are the key statistics about cervical cancer? http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-key-statisticsuri.
Last revised January 31, 2014. accessed June 9, 2014
|
|
3
|
Cancer.net. Cervical cancer: Statistics.
http://www.cancer.net/cancer-types/cervical-cancer/statisticsuri.
Last revised April 2014. accessed June 2014
|
|
4
|
Fidler IJ: Molecular biology of cancer:
Invasion and metastasis. Cancer: Principles and Practice of
Oncology. DeVita VT Jr, Hellman S and Rosenberg SA: 5th edition.
Lippincott-Raven; Philadelphia, PA: pp. 135–152. 1997
|
|
5
|
Rath M and Pauling L: Plasmin-induced
proteolysis and the role of apoprotein(a), lysine and synthetic
lysine analogs. J Orthomol Med. 7:17–23. 1992.
|
|
6
|
Andreasen PA, Kjøller L, Christensen L and
Duffy MJ: The urokinase-type plasminogen activator system in cancer
metastasis: a review. Int J Cancer. 72:1–22. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niedzwiecki A, Roomi MW, Kalinovsky T and
Rath M: Micronutrient synergy - a new tool in effective control of
metastasis and other key mechanisms of cancer. Cancer Metastasis
Rev. 29:529–542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roomi MW, Kalinovsky T, Rath M and
Niedzwiecki A: Modulation of u-PA, MMPs and their inhibitors by a
novel nutrient mixture in human female cancer cell lines. Oncol
Rep. 28:768–776. 2012.PubMed/NCBI
|
|
9
|
Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Suppression of human cervical cancer cell
lines HeLa and DoTc2 4510 by a mixture of lysine, proline, ascorbic
acid and green tea extract. Int J Gynecol Cancer. 16:1241–1247.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stetler-Stevenson WG: The role of matrix
metalloproteinases in tumor invasion, metastasis and angiogenesis.
Surg Oncol Clin N Am. 10:383–392. 2001.
|
|
11
|
Asha Nair S, Karunagaran D, Nair MB and
Sudhakaran PR: Changes in matrix metalloproteinases and their
endogenous inhibitors during tumor progression in the uterine
cervix. J Cancer Res Clin Oncol. 129:123–131. 2003.PubMed/NCBI
|
|
12
|
Zhou CY, Yao JF and Chen XD: Expression of
matrix metalloproteinase-2,9 and their inhibitor-TIMP 1,2 in human
squamous cell carcinoma of uterine cervix. Ai Zheng. 21:735–739.
2002.(In Chinese). PubMed/NCBI
|
|
13
|
Bonfil RD, Bustuoabad OD, Ruggiero RA,
Meiss RP and Pasqualini CD: Tumor necrosis can facilitate the
appearance of metastases. Clin Exp Metastasis. 6:121–129. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonfil RD, Medina PA, Gómez DE, Farías E,
Lazarowski A, Lucero Gritti MF, Meiss RF and Bustuoabad OD:
Expression of gelatinase/type IV collagenase in tumor necrosis
correlates with cell detachment and tumor invasion. Clin Exp
Metastasis. 10:211–220. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fujiwaki R, Hata K, Lida K, Maede Y and
Miyazaki K: Vascular endothelial growth factor expression in
progression of cervical cancer: correlation with thymidine
phosphorylase expression, angiogenesis, tumor cell proliferation
and apoptosis. Anticancer Res. 20:1317–1322. 2000.PubMed/NCBI
|
|
16
|
Mathur SP, Mathur RS, Gray EA, Lane D,
Underwood PG, Kohler M and Creasman WT: Serum vascular endothelial
growth factor C (VEGF-C) as a specific biomarker for advanced
cervical cancer: Relationship to insulin-like growth factor II
(IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
Gynecol Oncol. 98:467–483. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Argilés JM, Busquets S, Toledo M and
López-Soriano FJ: The role of cytokines in cancer cachexia. Curr
Opin Support Palliat Care. 3:263–268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deans C and Wigmore SJ: Systemic
inflammation, cachexia and prognosis in patients with cancer. Curr
Opin Clin Nutr Metab Care. 8:265–269. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roomi MW, Kalinovsky T, Roomi NW, Rath M
and Niedzwiecki A: Inhibition of growth and expression of
inflammation mediators in human leukemic cell line U-937 by a
nutrient mixture. Exp Oncol. 35:180–186. 2013.PubMed/NCBI
|
|
20
|
Roomi MW, Kalinovsky T, Niedzwiecki A and
Rath M: Pleiotropic effects of a micronutrient mixture on critical
parameters of bladder cancer. Bladder Cancer: Etymology, Diagnosis
and Treatments. Nilsson WE: Nova Science Publishers Inc; Hauppage,
NY: pp. 229–244. 2009
|
|
21
|
Aliya S, Reddanna P and Thyagaraju K: Does
glutathione S-transferase-Pi (GST-Pi) a marker protein for cancer?
Mol Cell Biochem. 253:319–327. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Z, Chen YH, Wang P, et al: The
blockage of high-affinity lysine binding sites of plasminogen by
EACA significantly inhibits prourokinase-induced plasminogen
activation. Biochem Biophys Acta. 1596:182–192. 2002.
|
|
23
|
Valcic S, Timmermann BN, et al: Inhibitory
effect of six green tea catechins and caffeine on the growth of
four selected human tumor cell lines. Anticancer Drugs. 7:461–468.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mukhtar H and Ahmed N: Tea polyphenols:
prevention of cancer and optimizing health. Am J Clin Nutr. (6
Suppl)71:1698S–1702S. 2000.PubMed/NCBI
|
|
25
|
Yang GY, Liao J, Kim K, Yurtow EJ and Yang
CS: Inhibition of growth and induction of apoptosis in human cancer
cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taniguchi S, Fujiki H, Kobayashi H, Go H,
Miyado K, Sadano H and Shimikawa R: Effect of (-)epigallocatechin
gallate, the main constituent of green tea, on lung metastasis with
mouse B16 melanoma cell lines. Cancer Lett. 65:51–54. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hara Y: Green tea: Health Benefits and
Applications. Marcel Dekker Inc; New York, NY: 2001, View Article : Google Scholar
|
|
28
|
Kawakami S, Kageyama Y, Fujii Y, Kihara K
and Oshima H: Inhibitory effects of N-acetyl cysteine on invasion
and MMP-9 production of T24 human bladder cancer cells. Anticancer
Res. 21:213–219. 2001.PubMed/NCBI
|
|
29
|
Morini M, Cai T, Aluigi MG, et al: The
role of the thiol N-acetyl cysteine in the prevention of tumor
invasion and angiogenesis. Int J Biol Markers. 14:268–271.
1999.
|
|
30
|
Yoon SO, Kim MM and Chung AS: Inhibitory
effects of selenite on invasion of HT1080 tumor cells. J Biol Chem.
276:20085–20092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cha J, Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Ascorbate supplementation inhibits growth
and metastasis of B16FO melanoma and 4T1 breast cancer cells in
vitamin C-deficient mice. Int J Oncol. 42:55–64. 2013.
|
|
32
|
Naidu KA, Karl RC and Coppola D:
Antiproliferative and proapoptotic effect of ascorbyl stearate in
human pancreatic cancer cells: association with decreased
expression of insulin-like growth factor 1 receptor. Dig Dis Sci.
48:230–237. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Anthony HM and Schorah CJ: Severe
hypovitaminosis C in lung-cancer patients: the utilization of
vitamin C in surgical repair and lymphocyte-related host
resistance. Br J Cancer. 46:354–367. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maramag C, Menon M, Balaji KC, Reddy PG
and Laxmanan S: Effect of vitamin C on prostate cancer cells in
vitro: effect on cell number, viability and DNA synthesis.
Prostate. 32:188–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koh WS, Lee SJ, Lee H, Park C, Park MH,
Kim WS, Yoon SS, Park K, Hong SI, Chung MH and Park CH:
Differential effects and transport kinetics of ascorbate
derivatives in leukemic cell lines. Anticancer Res. 18:2487–2493.
1998.PubMed/NCBI
|
|
36
|
Chen Q, Espey MG, Krishna MC, Mitchell JB,
Corpe CP, Buettner GR, Shacter E and Levine M: Pharmacologic
ascorbic acid concentrations selectively kill cancer cells: action
as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl
Acad Sci USA. 102:13604–13609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nuñez Martin C and Ortiz de Apodaca y Ruiz
A: Ascorbic acid in the plasma and blood cells of women with breast
cancer. The effect of consumption of food with an elevated content
of this vitamin. Nutr Hosp. 10:368–372. 1995.(In Spanish).
|
|
38
|
Kurbacher CM, Wagner U, Kolster B,
Andreotti PE, Krebs D and Bruckner HW: Ascorbic acid (vitamin C)
improves the antineoplastic activity of doxorubicin, cisplatin and
paclitaxel in human breast carcinoma cells in vitro. Cancer Lett.
103:183–189. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cooke JP and Dzau VJ: Nitric oxide
synthase: role in the genesis of vascular disease. Annu Rev Med.
48:489–509. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Roomi MW, Ivanov V, Netke SP, Niedzwiecki
A and Rath M: Serum markers of the liver, heart, and kidney and
lipid profile and histopathology in female ODS rats treated with
nutrient synergy. In: Presented at: American College of Nutrition;
Nashville, TN. (abstract 86). 22. pp. 4772003
|
